Thursday November 8, 2012

7:30

   Registration Opens

   Hall A

Hall B

Hall C

9:00-10:00

   Opening ceremony

10:00-10:45

   Keynote lecture 1

  “The Biological Basis of Consciousness” (DO Wiebers, USA)

10:45-11:30

   Keynote lecture 2

  "Western Pacific ALS-PDC: from epidemiology and systems biology to       etiology” (PS Spencer, USA)

11:30-12:30

   Plenary Session 1: New frontiers in neuroepidemiology

• Imaging Genetics: the new frontier in neuroepidemiology" (MA Ikram, The Netherlands).
• Contributions of the Rochester Epidemiology Project to neurology (W Rocca, USA)

12:30-13:30

   Lunch Break, Exhibition and Poster Viewing

Satellite symposium

13:30-15:00

   Plenary Session 2: Stroke Care and Prevention

• Obesity and stroke: does the size matter? INTERSTROKE study and literature overview (M O’Donnel, Ireland)
• Stroke issues in a developing country (TK Banerjee, India)
• Usefulness of national stroke surveys (N Bornstein, Israel)
• Role of industry in promoting stroke prevention and heart health (G Mensah, USA)

15:00–16:30

   Plenary Session 3: Treatment and NeuroRehabilitation

• Updates on essential tremor (E Louis, USA)
• Stroke management and clinical researches in China (M Liu, China)
• Differentiation of mesenchymal stromal stem cells as a potential future treatment of neurological disorders (C Brodie, Israel)
• Guiding Neurological Surgery by Evidence-Based Experience (H von Holst, Sweden)

16:30–17:00

   Coffee Break, Exhibition and Poster Viewing

17:00–18:30

   Plenary Session 4: Dementia and aging

• Oophorectomy, menopause, and estrogen treatment in brain aging (W Rocca, USA)
• Updates on white matter lesions/silent infarcts and the risk of dementia (C Tzourio, France)
• Lesions of subcortico-cortical  networks in vascular dementia (M Hennerichi, Germany)
• Prevention of AD: evidence from new multi-domain intervention trials (M Kivipelto, Sweden)

19:00

   Get together reception

Friday November 9, 2012

7:30

   Registration Opens

   Hall A

Hall B

Hall C

9:00–10:30

   Plenary Session 5: Translational neuroscience: a practical approach

• Silent cerebrovascular disease - an emerging epidemic (B Norring, Denmark)
• Gene-environment interactions mediating experience-dependent plasticity in the healthy and diseased brain (AJ Hannan, Australia)
• Cellular treatment of neuroinflamatory and neurodegenerative disorders at the patient's bedside (S Slavin, Israel)

10:30-11:00

   Coffee Break, Exhibition and Poster Viewing

11:00-12:30

   Plenary Session 6: Updates on Parkinson’s Disease

• Updates on Management of Parkinson’s Disease (TBC)
• Parkinson's Disease Epidemiology Update (H Chen, USA)
• Do we need a new definition of PD? (A Korczyn, Israel)

12:30-13:30

   Lunch Break, Exhibition and Poster Viewing. Hall B: Satellite Symposium

   of the WFN "What is an environmental factor?"

• Intruduction (J Reis, France)
• Gluten intolerance: when nutrition is an environmental factor (L Prockop, USA)
• When the environmental factor appears multifactorial: Nodding Syndrome (P Spenser, USA)
• Pesticides and risk of Parkinson's disease (W Rocca, USA)

Satellite symposium of the World Federation of Neurology

13:30-15:00

   Plenary Session 7: Epilepsy & Neurodegenerative disorders

• Long-term prognosis of epilepsy (E Beghi, Italy)
• Essential tremor and its Associations with Other Neurodegenerative Diseases: What is the Epidemiological Evidence? (E Louis, USA)
• Updates on epidemiology and management of epilepsy (E Beghi, Italy)

15:00-16:30

   Plenary Session 8: "ICD-11: implications for neurology"

• Updates on classification of cerebrovascular disease (B Norring, Denmark)
• Should we use different classifications for different purposes? (E Beghi, Italy)
• Do we need a new definition of Parkinson’s Disease? (A Korczyn, Israel)

16:30-17:00

   Coffee Break, Exhibition and Poster Viewing

17:00-18:30

   Plenary Session 9: “Rare neurogenetic disease: practical approach"

• A rare neurogenetic disease with fatal progressive course, that can be prevented by proactive screening and early intervention (TBC)
• Understanding of pahtophysicological mechanism of NP-C help to develop novel specific biomarkers which may be used for early detection and intervention of the disease (TBC)
• Updates on the management of type 1 Gaucher disease (TBC)

Saturday November 10, 2012

7:30

   Registration Opens

   Hall A

Hall B

Hall C

9:00 – 10:30

   Plenary Session 10: “Methodological issues in Neuroepidemiology

• Neuroepidemiological extension to STROBE (C Brayne, UK)
• Epidemiology of rare neurological disorders (G Logroscino, Italy)
• Beyond clinical trials (G Logroscino, Italy)

10:30 –11:00

   Coffee Break, Exhibition and Poster Viewing

11:00 –12:30

   Plenary Session 11: “Updates on Multiple Sclerosis”

• The Origin and Spread of Multiple Sclerosis in Europe (J Kurtzke, USA)
• Status of multiple sclerosis in developing countries (JD Pandian, India)
• Epidemiology and prevention of multiple sclerosis (B Taylor, Australia)

12:30 –13:30

   Lunch Break, Exhibition and Poster Viewing

Satellite symposium

13:30 –15:00

   Plenary Session 12: Controversies in the management of                neurological disorders

• Strategic management of stroke recurrence (K Nagata, Japan)
• Why have we failed to find a cure for AD? (A Korczyn, Israel)

• Diagnosis and management of multiple sclerosis (J Kesselring, Switzerland)

15:00 - 16:30

   Plenary Session 13: “Alternative medicine and rehabilitation in    neurological disorders”

• Alternative medicine use in the treatment of neurological disorders: an overview (JD Pandian, India)
• Evidence for cognitive enhancement in the elderly and Alzheimer's patients using herbal medicines (C Stough, Australia)
• Community-based stroke rehabilitation in China (W Wong, China)

16:30 –17:00

   Lunch Break, Exhibition and Poster Viewing

Satellite symposium

17:00 –17:30

Concluding remarks, award ceremony